Investor Relations

Overview
Quarterly Results
News
Governance
Financials
SEC Filings

RCM Technologies Overview

Learn About Us

RCM Technologies, Inc. (Nasdaq: RCMT) is a business and technology solutions provider with world-class talent in key market segments. We help design, build, and enable the Industries of Tomorrow, Today. Operating at the intersection of resources, critical infrastructure, and modernization of industries through advanced technologies. RCM is a provider of services in Health Care, Engineering, Aerospace & Defense, Process & Industrial, Life Sciences and Data & Solutions.

Earnings

See More Earnings

Financial Summary Table

FY 2025FY 2024FY 2023FY 2022
Press ReleaseQ1 Q2 Q3 Q4Q1 Q2 Q3 Q4Q1 Q2 Q3 Q4Q1 Q2 Q3 Q4
Earnings TranscriptQ1 Q2 Q3 Q4Q1 Q2 Q3 Q4Q1 Q2 Q3 Q4Q1 Q2 Q3 Q4
10-Q & 10-KQ1 Q2 Q3 Q4Q1 Q2 Q3 Q4Q1 Q2 Q3 Q4Q1 Q2 Q3 Q4
Webcasts / Audio FilesQ1 Q2 Q3 Q4Q1 Q2 Q3 Q4Q1 Q2 Q3 Q4Q1 Q2 Q3 Q4
RCM Technologies, Inc. Financial Summaries

Distributions

The Internal Revenue Service (IRS) requires RCM to post the completed forms 8937 on the Company’s website. RCM shareholders may refer to this information in preparation of their tax return.  RCM does not advise any further on shareholder tax matters. Please refer to a tax professional for further advice. Thank you.

2017 RCM Form 8937

2015 RCM Form 8937

2014 RCM Form 8937

2012 RCM Form 8937

Corporate Governance

Anti-Harassment PolicyAudit Committee CharterCode of Conduct
Code of EthicsCompensation Committee CharterSexual Harassment Policy
Conflicts of InterestCorporate Governance GuidelinesDrug Free Workplace Policy
Electronic CommunicationsEqual Employment Opportunity PolicyWorkplace Violence Policy
Insider Trading PolicyNominating and Corporate Governance Committee Charter Social Security Number Privacy Policy
Stock Ownership GuidelinesCompliance Policy
RCM Technologies, Inc. Corporate Governance

Board of Directors

BRADLEY S. VIZI

Executive Chairman & President

Mr. Vizi has served as our Executive Chairman & President since June of 2018. Previously, Mr. Vizi served as our Chairman of the Board since September of 2015 and a board member since December of 2013. Mr. Vizi’s significant public company experience is particularly valuable in the areas of strategy, capital allocation, compensation planning, corporate governance and marketing the Company to the investment community.

From February 2016 to June 2022, Mr. Vizi served as a member of the Board of Directors at L.B. Foster (NASDAQ: FSTR), a leading manufacturer, fabricator, and distributor of products and services for the rail, construction, energy and utility markets with locations in North America and Europe. 

Mr. Vizi founded Legion Partners Management, Inc. in 2010 and Legion Partners Asset Management, LLC in 2012, where he served as Managing Director and Portfolio Manager until October 2017. From 2007 to 2010, Mr. Vizi was an investment professional at Shamrock Capital Advisors, Inc.
(“Shamrock”), the alternative investment vehicle of the Disney Family.

Prior to Shamrock, from 2006 to 2007, Mr. Vizi was an investment professional with the private equity group at Kayne Anderson Capital Advisors L.P. Mr. Vizi is a CFA Charterholder and graduated from the Wharton School at the University of Pennsylvania.

CHIGOZIE O. AMADI

Director since 2022

Mr. Amadi has served since October 2019 as the Chief Financial Officer for The Siegel Group, a conglomerate of private companies focusing on investments and management of real estate and food and beverage businesses. Mr. Amadi leads the departments of accounting, finance, payroll, acquisitions, and dispositions. Before his current role, Mr. Amadi previously served as Director of Real Estate Investments for The Siegel Group. Mr. Amadi also worked for Wells Fargo & Company, providing secured and unsecured financing to REITs and private real estate firms. Mr. Amadi holds a J.D. from Loyola Law School and a B.A. from the University of Pennsylvania and is an active member of the California Bar.

Mr. Amadi’s extensive experience overseeing the preparation and aggregation of the financial performance of multiple companies, in addition to supervising the audits and financial professionals responsible for those audits, and his legal acumen, allow him to make valuable contributions to all of the Company’s business segments.

SWARNA KAKODKAR

Director, 2019-Present

Ms. Kakodkar is a seasoned technology executive with over 15 years of experience building organizations that develop high-impact software to serve enterprises, developers, and consumers. Ms. Kakodkar’s extensive experience in digital marketing, financial modeling, enterprise software, implementation of new technologies and management and retention of diverse employee groups allow her to make valuable contributions to all of the Company’s business segments.

Ms. Kakodkar currently leads a product management organization at Google. She previously led product and technical teams at Amazon Web Services, where she launched services that touched millions of users. Prior to that, she held various roles at Facebook, where she oversaw the development of digital advertising products and global partnerships with some of Facebook’s largest customers. Before joining Facebook, Ms. Kakodkar worked at AOL Platforms, where she developed capital allocation strategies, managed M&A activity and built technology partnership programs.

Ms. Kakodkar chairs our Compensation Committee, serves on our Audit Committee, and serves on our Nominating/Governance Committee.
Ms. Kakodkar holds an MBA from Harvard Business School and a BA from Harvard College.

JAYANTH S. KOMARNENI

Director since 2020

Mr. Komarneni is the founder and chair of the Human Diagnosis Project (‘Human Dx’), an open medical intelligence system. Human Dx has brought together top medical organizations (including the American Medical Association, the American Board of Medical Specialties, and the National Association of Community Health Centers), health systems (including research collaborations with Harvard, Johns Hopkins, UCSF, Stanford, and Kaiser Permanente), and financial supporters (including the European Union, the MacArthur Foundation, the Gordon & Betty Moore Foundation, Union Square Ventures, and Andreessen Horowitz). Before founding Human Dx, Mr. Komarneni advised leadership at some of the world’s preeminent organizations while working at McKinsey & Company and Bain & Company.

Mr. Komarneni’s work spanned stakeholders in the social, public, and private sectors, including foundations, governments, companies (in the life sciences, health care, technology, energy, and financial services industries), and alternative investment firms. After McKinsey and Bain, he helped launch and operate Greenoaks Capital Management, a global alternative investment firm, as its first employee.

Mr. Komarneni also participated in Y Combinator, the world’s leading technology accelerator. Mr. Komarneni has degrees that include an MSc in Global Health Science from the University of Oxford and an MBA from the Wharton School, and an MS in Biotechnology from the School of Engineering and Applied Science at the University of Pennsylvania.

Mr. Komarneni’s prior background founding, advising, and working at leading organizations in the technology, healthcare, investment, professional services, and life sciences industries helps contribute across RCM’s diverse business segments from strategic and operational perspectives.

Corporate businesspeople meeting in the boardroom.

How can we help?

If you have questions about RCM’s investment policy or corporate governance, contact us today.

Contact us